GEN-MKT-18-7897-A
Mar 25, 2022 | Blogs, Food / Beverage, Food and Beverage | 0 comments
Read time: 2 minutes
As we become more conscious about the planet, healthier lifestyles and our duty to protect the environment, attitudes and behaviours are shifting when it comes to food consumption.
‘Fake’ meat and the environment
Nowadays, meat or fish is part of every meal for a lot of people, meaning farming has had to meet (pardon the pun) these demands. To achieve this, most farmers are forced to unnaturally feed livestock to ‘fatten them up’ which is becoming increasingly unsustainable for our environment.1
Luckily, the meat alternatives, plant-based products are becoming more widely available in supermarkets, and even better, more affordable! Some people would argue that the vegetarian lifestyle is a healthier choice to make. Generally, vegetables are good for you and some people would assume plant-based meat is healthier than regular meat…But this might not always be the case.2 Let’s dig into why.
Keeping the ‘fake’ meat experience ‘real’
Yes, plant-based alternatives have become to provide similar, if not the same protein alternatives to meat products.2 However, in order to achieve the real meat experience consumers anticipate, synthetic biology companies carefully investigate the taste and texture these products provide to consumers. To help achieve the correct flavours, additives such as fats and oils are often used. The source of these fat matter as the profiles differ and although some might be beneficial to consumers health, others have the potential to be harmful.2
Testing for lipids in meat products
To ensure consumers know exactly what is in their alternative meat products, it is vital each component in products is quantified and packaging is labelled properly. Using the SCIEX 7500 system to profile and identify the lipid composition of meat and meat alternatives samples, discover how this method can improve consume confidence.
References
RUO-MKT-18-14251-A
In biopharmaceutical development, sequence variants (SV) are considered an inherent risk of producing complex proteins in living systems. Sequence variants are unintended changes to the amino acid sequence of a biotherapeutic and can be caused by errors in transcription or translation in the host cell, or cell culture and process conditions. Detailed analysis of SVs is important in process and product development to ensure the drug’s safety and efficacy. Even low‑level sequence variants can have significant implications for product quality, safety, and efficacy, making their accurate detection and characterization a critical requirement across development, process optimization, and regulatory submission.
CE‑SDS remains a cornerstone assay for characterizing fragmentation, aggregation, and product‑related impurities in therapeutic proteins. UV detection has been the long‑standing standard. However, it frequently struggles with baseline noise, limited sensitivity for minor fragments, and subjective integration.
At SCIEX, innovation doesn’t stop at instruments; it extends to how you interact with your LC-MS/MS or CE systems every day. That’s why we’re excited to introduce the SCIEX Now spring 2026 improvements: a set of meaningful enhancements shaped directly by your feedback.
Posted by
You must be logged in to post a comment.
Share this post with your network